ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Insulin, Regular, Human

Also written as “Technosphere Insulin”, “inhaled human insulin” and “Human Insulin Inhalation Powder”.

Its studies are mostly in Diabetes Mellitus, Type 2 · Diabetes Mellitus, Type 1 · Diabetes Mellitus · Asthma · Diabetes, Gestational, led by 13 companies.

Drug pageInsulin, Regular, Human: every studyMany companies study it; this page follows only the 79 they lead. All 127 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Apr 16, 202179 company-led studies, 2 open or runningNext primary completion: Mar 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Mannkindits history only261 open or runningphase 4since Apr 16, 2021Mar 27, 2006Mar 2027phase 2 · NCT07224321
Novo Nordisk190 open or runningphase 4since Aug 10, 2006Jul 17, 2003none ahead
Eli Lillyits history only100 open or runningphase 4since Jan 22, 2013Aug 4, 2005none ahead
Biodelits history only50 open or runningphase 3since Oct 5, 2007Oct 5, 2007none ahead
Pfizerits history only40 open or runningphase 3since Feb 2, 2006Feb 2, 2006none ahead
Dance Biopharmits history only30 open or runningphase 2since Mar 9, 2016Mar 9, 2016none ahead
Halozyme Therapeuticsits history only30 open or runningphase 2since Oct 15, 2008Jun 24, 2008none ahead
Sanofiits history only30 open or runningphase 4since Jun 26, 2012Sep 2, 2010none ahead
Transdermal Delivery Solutionsits history only21 open or runningphase 3since Dec 1, 2021Apr 21, 2021Oct 15, 2027phase 3 · NCT05159453
Diabetes and Glandular Disease Clinicits history only10 open or runningphase 4since Oct 9, 2019Oct 9, 2019none ahead

Also a collaborator on its studies: Langford Research Institute, Insulet, DexCom, Profil Institut für Stoffwechselforschung, Alkermes, WCCT Global and Nektar Therapeutics.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Novo Nordisk only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 3 studies since Jul 17, 2003.

  1. Jul 5, 2006Phase 3 study in Diabetes MellitusNCT00348712 · 301 enrolled · Austria, Finland, France and more
  2. Aug 10, 2006Phase 4 study in Diabetes MellitusNCT00365170 · 419 enrolled · Argentina, Austria, Bulgaria and more
  3. Dec 11, 2006No phase study in Diabetes MellitusNCT00410033 · 74 enrolled · Sweden
  4. Jan 8, 2007Phase 1 study in Diabetes MellitusNCT00419718 · 23 enrolled · Austria
  5. Jan 25, 2007Phase 3 study in Diabetes MellitusNCT00427154 · 227 enrolled · United States
  6. May 3, 20073 phase 3 studies in Diabetes MellitusNCT00469586, NCT00472953, NCT00476437
  7. Aug 29, 2007Phase 3 study in Diabetes MellitusNCT00523042 · 10 enrolled · United States, Australia, Former Serbia and Montenegro and more
  8. Nov 30, 2007Phase 2 study in Diabetes MellitusNCT00567775 · 27 enrolled · Denmark
  9. Dec 5, 2007Phase 3 study in Diabetes MellitusNCT00569400 · 241 enrolled · Australia, Hong Kong, Malaysia and more
  10. Feb 6, 2008Phase 3 study in Diabetes MellitusNCT00617565 · 219 enrolled · China
  11. May 9, 2008Phase 4 study in Diabetes MellitusNCT00676819 · 19 enrolled · Germany
  12. Jul 29, 2008Phase 3 study in Diabetes MellitusNCT00725036 · 305 enrolled · Australia
  13. Jan 3, 2011Phase 1 study in Diabetes MellitusNCT01269606 · 13 enrolled · Japan
  14. Oct 5, 2011Phase 1 study in Diabetes MellitusNCT01448070 · 28 enrolled · United Kingdom

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 19 Novo Nordisk leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT01448070Diabetes Mellitus · United Kingdom1CompletedDec 20, 200228
NCT01269606Diabetes Mellitus · Japan1CompletedMar 201113
NCT00725036Diabetes Mellitus · Australia3CompletedDec 14, 2004305
NCT00676819Diabetes Mellitus · Germany4CompletedJul 19, 200219
NCT00617565Diabetes Mellitus · China3CompletedNov 26, 2003219
NCT00569400Diabetes Mellitus · Australia, Hong Kong, Malaysia and more3CompletedJan 19, 2004241
NCT00567775Diabetes Mellitus · Denmark2CompletedNov 20, 200227
NCT00523042Diabetes Mellitus · United States, Australia, Former Serbia and Montenegro and more3TerminatedFeb 28, 200810
NCT00476437Diabetes Mellitus · Japan3CompletedNov 200781
NCT00472953Diabetes Mellitus · Argentina, India, Romania and more3TerminatedMar 5, 200838
NCT00469586Diabetes Mellitus · Argentina, Austria, Belgium and more3TerminatedApr 24, 2008174
NCT00427154Diabetes Mellitus · United States3TerminatedMar 11, 2008227
NCT00419718Diabetes Mellitus · Austria1CompletedNov 200523
NCT00410033Diabetes Mellitus · Sweden–CompletedMay 200674
NCT00365170Diabetes Mellitus · Argentina, Austria, Bulgaria and more4CompletedApr 2005419
NCT00348712Diabetes Mellitus · Austria, Finland, France and more3TerminatedMar 5, 2008301
NCT00343980Diabetes Mellitus · Australia, Croatia, India and more3TerminatedMar 10, 2008363
NCT00331604Diabetes Mellitus · Brazil, Denmark, France and more3TerminatedMay 5, 2008618
NCT00065130Diabetes Mellitus · United States3CompletedDec 200327

How it is read

Names in the registry

  • “Technosphere Insulin”, 13 entries
  • “inhaled human insulin”, 12 entries
  • “Human Insulin Inhalation Powder”, 7 entries
  • “human insulin”, 7 entries
  • “Technosphere® Insulin Inhalation Powder”, 5 entries

Codes read as this program: INH69, INH139, INH208, HR1799.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.